Navigation Links
The First Years True Fit C630 Convertible Car Seat Recieves Highest Given Rating From the National Highway Traffic Safety Administration
Date:10/30/2008

C630 Convertible Car Seat earns top honors for a four-star ease of use

rating for both rear and front facing positions!

OAK BROOK, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Learning Curve Brands, Inc., a wholly owned subsidiary of RC2 Corporation (Nasdaq: RCRC) (http://www.learningcurve.com), was recently recognized by the National Highway Traffic Safety Administration (NHTSA), giving The First Years True Fit C630 Convertible Car Seat a four-star Ease of Use rating. The C360 was the only seat to earn a four-star rating in both the rear and front facing positions out of the 22 convertible car seats tested.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU175LOGO)

The First Years True Fit C630 Convertible Car Seat was rated four stars by NHTSA for its ease of use pertaining to instructions, installation features, labels, and securing the child. To see the convertible seat ratings, visit http://www.nhtsa.gov/.

NHTSA is an agency of the Executive Branch of the U.S. Government making it part of the Department of Transportation. Its mission is to "save lives, prevent injuries and reduce economic costs due to road traffic crashes, through education, research, safety standards and enforcement activity." All car seats rated by NHTSA meet Federal Safety Standards & strict crash performance standards, but differ in their ease of use. NHTSA believes "an easy to use child restraint can result in more children being properly restrained," according to agency documents.

"The four-star rating from the NHTSA proves Learning Curve is dedicated to making quality products that make parenting easier," states Pete Henseler, President of Learning Curve Brands, Inc. "We are proud that our C630 Convertible Car Seat earned the highest Ease of Use ratings given to a convertible car seat. It joins our B510 Booster Seat which earned the highest Ease of Use rating earlier this year, making both seats easy-to-use restraints that can help keep children safe."

For more information on The First Years True Fit C630 visit: http://www.learningcurve.com/truefit

About Learning Curve Brands, Inc.

Learning Curve Brands, Inc. (http://www.learningcurve.com) is a wholly owned subsidiary of RC2 Corporation (NASDAQ: RCRC, http://www.rc2.com) and is a leading designer, producer and marketer of innovative, high-quality toys, collectibles, and infant and toddler products. Learning Curve Brands, Inc. markets its infant, toddler and preschool products under its Learning Curve(R) family of brands which includes The First Years(R) by Learning Curve and Lamaze brands as well as popular and classic licensed properties such as Thomas & Friends, Bob the Builder, Winnie the Pooh, John Deere, Nickelodeon and Sesame Street. The Company's youth and adult products are marketed under the Johnny Lightning(R) (http://www.johnnylightning.com) and Ertl(R), (http://www.ertl.com) brands. Learning Curve Brands, Inc. reaches its target consumers through multiple channels of distribution supporting more than 25,000 retail outlets throughout North America, Europe, Australia, and Asia Pacific.


'/>"/>
SOURCE Learning Curve Brands, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First evidence that prenatal exposure to famine may lead to persistent epigenetic changes
2. Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special
3. WPI receives award from Homeland Security Department to advance first-responder location
4. First Results from Hospital Trials Show Pathogens Stay Close to Patients
5. NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders
6. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
7. Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use
8. Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award
9. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
10. P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth
11. Cardinal Health Reports First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center for ... and wellness program, at their world headquarters of Omni La Costa Resort & Spa ... to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and physical ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
(Date:12/8/2016)... Payne, AL (PRWEB) , ... December 08, 2016 ... ... offering insurance and financial consulting services to residential and commercial clients in the ... awareness and support for Nobis Works. , Since 1977, Nobis Works has built ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: